Loading company
Talphera, Inc.
TLPH · Nasdaq · ·
Next earnings: November 11, 2026
$1.18-1.3%Sep 29 close
- 1M
- -2.1%
- 6M
- +57.5%
- 1Y
- +31.5%
- 5Y
- -94.5%
TLPH · Nasdaq · ·
Next earnings: November 11, 2026
$1.18-1.3%Sep 29 close
Talphera, Inc. is scheduled to report next on November 11, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $0.00 | $0.00 | — |
| Profit | -$4.3M | -$3.5M | -23.59% |
| Profit per share | -$0.10 | -$0.40 | +75.00% |
| Free Cash Flow | -$2.3M | -$3.9M | +42.92% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Releases land after the close or before the open, so the move is the session that follows.
Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad® is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA). This release is intended for investors only. For additional information about Talphera, please visit www.talphera.com .
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Talphera, Inc.’s Item 2.02 8-K filed August 12, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Talphera, Inc. has no earnings call transcript available.